DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,790,754 | -0.5% | 55,585 | -3.8% | 1.57% | +4.2% |
| Q2 2023 | $13,862,988 | -11.1% | 57,762 | -6.6% | 1.51% | -20.8% |
| Q1 2023 | $15,594,833 | -8.8% | 61,874 | -3.9% | 1.91% | -15.8% |
| Q4 2022 | $17,096,346 | -2.6% | 64,412 | -2.1% | 2.26% | +2.2% |
| Q3 2022 | $17,553,000 | +4.0% | 65,809 | -1.1% | 2.22% | -0.4% |
| Q2 2022 | $16,873,000 | -16.6% | 66,554 | -3.5% | 2.22% | -6.4% |
| Q1 2022 | $20,234,000 | -14.4% | 68,981 | -4.0% | 2.38% | -7.9% |
| Q4 2021 | $23,643,000 | +1.0% | 71,860 | -6.6% | 2.58% | -13.2% |
| Q3 2021 | $23,416,000 | -5.4% | 76,914 | -2.0% | 2.97% | -0.5% |
| Q2 2021 | $24,748,000 | +41.9% | 78,499 | +1.3% | 2.99% | +15.8% |
| Q1 2021 | $17,437,000 | +1.7% | 77,470 | +0.4% | 2.58% | -2.5% |
| Q4 2020 | $17,146,000 | -8.3% | 77,185 | -3.1% | 2.64% | -12.7% |
| Q3 2020 | $18,689,000 | +27.5% | 79,634 | -3.9% | 3.03% | +5.4% |
| Q2 2020 | $14,657,000 | +21.7% | 82,889 | -4.8% | 2.87% | -4.5% |
| Q1 2020 | $12,045,000 | -10.4% | 87,024 | -0.6% | 3.01% | +15.8% |
| Q4 2019 | $13,437,000 | +7.6% | 87,551 | +1.2% | 2.60% | -3.4% |
| Q3 2019 | $12,491,000 | -2.5% | 86,488 | -3.5% | 2.69% | -6.6% |
| Q2 2019 | $12,812,000 | +8.7% | 89,645 | +0.4% | 2.88% | +3.7% |
| Q1 2019 | $11,788,000 | +27.0% | 89,286 | -0.8% | 2.77% | +16.2% |
| Q4 2018 | $9,281,000 | -4.1% | 90,000 | +1.1% | 2.39% | +9.4% |
| Q3 2018 | $9,677,000 | +10.0% | 89,060 | -0.1% | 2.18% | +0.4% |
| Q2 2018 | $8,795,000 | +2.6% | 89,125 | +1.8% | 2.17% | +1.6% |
| Q1 2018 | $8,575,000 | +335.7% | 87,580 | +313.1% | 2.14% | +322.3% |
| Q4 2017 | $1,968,000 | +112.1% | 21,200 | +96.0% | 0.51% | +103.2% |
| Q3 2017 | $928,000 | +4.5% | 10,815 | +2.8% | 0.25% | -2.4% |
| Q2 2017 | $888,000 | +106.0% | 10,524 | +108.8% | 0.26% | +100.8% |
| Q1 2017 | $431,000 | +18.1% | 5,040 | +7.5% | 0.13% | +10.4% |
| Q4 2016 | $365,000 | -1.9% | 4,690 | -1.1% | 0.12% | -5.0% |
| Q3 2016 | $372,000 | -13.5% | 4,740 | +11.4% | 0.12% | -22.9% |
| Q2 2016 | $430,000 | +6.4% | 4,255 | 0.0% | 0.16% | +5.4% |
| Q1 2016 | $404,000 | +56.6% | 4,255 | +53.1% | 0.15% | +63.7% |
| Q4 2015 | $258,000 | +8.9% | 2,780 | 0.0% | 0.09% | +3.4% |
| Q3 2015 | $237,000 | +12.9% | 2,780 | +13.2% | 0.09% | +22.2% |
| Q2 2015 | $210,000 | – | 2,455 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |